Transporter |
Synonyms |
Inhibitor |
IC50 (μM) |
Ki (μM) |
Substrate used |
Cell System |
Reference |
SLC22A1 |
OCT1 |
Pentamidine |
0.4 |
|
1-methyl-4-phenylpyridinium (MPP+) |
HEK293-OCT1 |
Jung, 2008 |
SLC22A1 |
OCT1 |
Pentamidine |
22.1 |
|
4-(4-dimethylamino)styryl-N-methylpyridinium (ASP+) |
HEK293-OCT1 |
Wittwer, 2013 |
SLC22A3 |
OCT3 |
Pentamidine |
9.5 |
|
4-(4-dimethylamino)styryl-N-methylpyridinium (ASP+) |
HEK293-OCT3 |
Wittwer, 2013 |
SLC22A2 |
OCT2 |
Pentamidine |
1.2 |
|
4-(4-dimethylamino)styryl-N-methylpyridinium (ASP+) |
HEK293-OCT2 |
Wittwer, 2013 |
SLC47A1 |
MATE1 |
Pentamidine |
2.7 |
|
4-(4-dimethylamino)styryl-N-methylpyridinium (ASP+) |
HEK293-MATE1 |
Wittwer, 2013 |
SLC47A2 |
MATE2K |
Pentamidine |
2.7 |
|
4-(4-dimethylamino)styryl-N-methylpyridinium (ASP+) |
HEK293-MATE2K |
Wittwer, 2013 |
SLC47A2 |
MATE2K |
Pentamidine |
10.4 |
|
4-(4-dimethylamino)styryl-N-methylpyridinium (ASP+) |
HEK293-MATE2K |
Wittwer, 2013 |
ABCC2 |
MRP2, cMOAT |
Pentamidine |
>133 |
|
Estradiol-17beta-glucuronide |
Sf9 cell membrane vesicles |
Morgan, 2013 |
ABCC3 |
MRP3 |
Pentamidine |
>133 |
|
Estradiol-17beta-glucuronide |
Sf9 cell membrane vesicles |
Morgan, 2013 |
ABCC4 |
MRP4 |
Pentamidine |
>133 |
|
Estradiol-17beta-glucuronide |
Sf9 cell membrane vesicles |
Morgan, 2013 |
SLC47A1 |
MATE1 |
Pentamidine |
0.41 |
|
Metformin |
MDCK2- MATE1 |
Wittwer, 2013 |
SLC47A1 |
MATE1 |
Pentamidine |
2 |
|
Metformin |
HEK293-MATE1 |
Wittwer, 2013 |
SLC22A1 |
OCT1 |
Pentamidine |
16.4 |
|
N-methylpyridinium |
CHO-OCT1 |
Ming, 2009 |
SLC22A2 |
OCT2 |
Pentamidine |
10.6 |
|
N-methylpyridinium |
CHO-OCT2 |
Ming, 2009 |
SLC22A3 |
OCT3 |
Pentamidine |
14.8 |
|
N-methylpyridinium |
CHO-OCT3 |
Ming, 2009 |
ABCB11 |
BSEP |
Pentamidine |
>133 |
|
Taurocholate |
Sf9 cell membrane vesicles |
Morgan, 2013 |
No drug-drug interaction information.